JHVEPhoto
Amedisys (NASDAQ:AMED) rose 1% in after hours trading after a divestiture agreement in its planned sale to UnitedHealth (NYSE:UNH) that may help it secure regulatory approval after the Dept. of Justice sued to block the combination in November.
Amedisys (